Showing 1 - 4 results of 4 for search 'Richard Hafner', query time: 0.03s
Refine Results
-
1
-
2
The China tuberculosis clinical trials consortium network: a model for international TB clinical trials capacity building by Yu-Hong Liu, Shu Chen, Jing-Tao Gao, Yao Zhang, Kimberly Booher, Xiao-Fen Ding, Wei Shu, Jian Du, Jing Bao, Richard Hafner, Carol D. Hamilton, Liang Li
Published 2020-05-01
Article -
3
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy by Ashley N. Brown, George L. Drusano, Jonathan R. Adams, Jaime L. Rodriquez, Kalyani Jambunathan, Dodge L. Baluya, David L. Brown, Awewura Kwara, Jon C. Mirsalis, Richard Hafner, Arnold Louie
Published 2015-12-01
Article -
4
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial by Andreas Diacon, ProfPhD, Sachiko Miyahara, PhD, Rodney Dawson, PhD, Xin Sun, PhD, Evelyn Hogg, Kathleen Donahue, MA, Michael Urbanowski, PhD, Veronique De Jager, MD, Courtney V Fletcher, ProfPharmD, Richard Hafner, MD, Susan Swindells, ProfMBBS, William Bishai, ProfMD
Published 2020-06-01
Article